PD-1+ percentage in CD8+ T cells in HCC were 74.76% (46.79%-84%) compared to PDA 62.96% (1.52%-82.83%) and CCA 56.4% (22.98%-79.77%), although not statistically significant. This evidence concerns the gene CD8A and hepatocellular carcinoma.